MedTrace Logo

Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel

NCT03144440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-01-31

No results posted yet for this study

Summary

Primary objective:

1\. To estimate the effectiveness of treatment with FDC of Zepatier with or without ribavirin in Israeli patients with CHC and advanced fibrosis in real life setting.

Secondary objective:

1\. To estimate the safety and tolerability of treatment with FDC of Zepatier with or without ribavirin in real life setting in Israeli patients with CHC and advanced disease.

Hypotheses:

Effectiveness and tolerability of treatment with FDC of Zepatier with or without ribavirin in Israeli patients with CHC and advanced fibrosis will be similar to that demonstrated in phase 3 clinical trials.

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-13
Primary Completion
2021-01-01
Completion
2021-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03144440 on ClinicalTrials.gov